结局变量,N,治疗效应系数,标准误,95%CI下限,95%CI上限,P值,R²,显著,控制变量,解释
ALT变化,265,-0.550377030790866,1.4734353077118307,-3.451815088258417,2.351061026676685,0.7090571906321698,0.03397582568680213,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组ALT变化无显著减少0.55单位
AST变化,265,-0.2767725094957083,1.0657261294160645,-2.3753636960523066,1.8218186770608902,0.7952990247895427,0.029940814641765567,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组AST变化无显著减少0.28单位
肝硬度变化,196,-0.2590452787561971,0.4698681210981902,-1.1858733894449882,0.6677828319325941,0.5820656086537935,0.4550838670972819,否,基线值+年龄+性别+是否合并脂肪肝,控制混杂因素后，治疗组肝硬度变化无显著减少0.26单位
